Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Jul;41(7):1541–1546. doi: 10.1128/aac.41.7.1541

Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro.

E S Didier 1
PMCID: PMC163955  PMID: 9210681

Abstract

Presently, the two most commonly used drugs for treating microsporidiosis in persons with AIDS are albendazole and fumagillin. Albendazole is effective for treating disseminated infections due to Encephalitozoon spp. but is variably effective against Enterocytozoon bieneusi infections. Fumagillin is highly effective when used topically to treat ocular infections with Encephalitozoon hellem or Encephalitozoon intestinalis but is too toxic for systemic use. In this study, the fumagillin analog TNP-470 was assayed for antimicrosporidial activity in vitro. The MICs of TNP-470 at which 50% of isolates were killed (MIC50s) were 0.35 +/- 0.21 and 0.38 +/- 0.11 ng/ml for E. intestinalis and Vittaforma corneae, respectively, and were similar to the MIC50s of fumagillin for these organisms, which were 0.515 +/- 0.002 and 0.81 +/- 0.014 ng/ml, respectively. The MIC50 of albendazole for E. intestinalis was 8.0 +/- 4.23 ng/ml, significantly less (P < 0.01) than its MIC50 for V. corneae, which was 55.0 +/- 7.07 ng/ml. TNP-470 inhibited replication of E. intestinalis in RK-13 cells if it was given at the same time as infection or if treatment was initiated 7 days later. In addition, treatment of the infected cultures with TNP-470 at a dose of 10 ng/ml for 2 weeks, followed by discontinuation of the drug treatment, resulted in no significant increase in E. intestinalis shedding during the following 3 weeks in culture. Because TNP-470 acts against both E. intestinalis and V. corneae, and because TNP-470 was found by others to be less toxic in vivo, TNP-470 may be a promising new drug for the treatment of microsporidiosis.

Full Text

The Full Text of this article is available as a PDF (163.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarons E. J., Woodrow D., Hollister W. S., Canning E. U., Francis N., Gazzard B. G. Reversible renal failure caused by a microsporidian infection. AIDS. 1994 Aug;8(8):1119–1121. doi: 10.1097/00002030-199408000-00013. [DOI] [PubMed] [Google Scholar]
  2. Antoine N., Bours V., Heinen E., Simar L. J., Castronovo V. Simulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis. J Natl Cancer Inst. 1995 Jan 18;87(2):136–139. doi: 10.1093/jnci/87.2.136. [DOI] [PubMed] [Google Scholar]
  3. Antoine N., Daukandt M., Heinen E., Simar L. J., Castronovo V. In vitro and in vivo stimulation of the murine immune system by AGM-1470, a potent angiogenesis inhibitor. Am J Pathol. 1996 Feb;148(2):393–398. [PMC free article] [PubMed] [Google Scholar]
  4. Beauvais B., Sarfati C., Challier S., Derouin F. In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi. Antimicrob Agents Chemother. 1994 Oct;38(10):2440–2448. doi: 10.1128/aac.38.10.2440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blanshard C., Ellis D. S., Dowell S. P., Tovey G., Gazzard B. G. Electron microscopic changes in Enterocytozoon bieneusi following treatment with albendazole. J Clin Pathol. 1993 Oct;46(10):898–902. doi: 10.1136/jcp.46.10.898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blanshard C., Ellis D. S., Tovey D. G., Dowell S., Gazzard B. G. Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. AIDS. 1992 Mar;6(3):311–313. doi: 10.1097/00002030-199203000-00009. [DOI] [PubMed] [Google Scholar]
  7. Cali A., Kotler D. P., Orenstein J. M. Septata intestinalis N. G., N. Sp., an intestinal microsporidian associated with chronic diarrhea and dissemination in AIDS patients. J Eukaryot Microbiol. 1993 Jan-Feb;40(1):101–112. doi: 10.1111/j.1550-7408.1993.tb04889.x. [DOI] [PubMed] [Google Scholar]
  8. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 51-1993. A 36-year-old man with AIDS, increase in chronic diarrhea, and intermittent fever and chills. N Engl J Med. 1993 Dec 23;329(26):1946–1954. doi: 10.1056/NEJM199312233292609. [DOI] [PubMed] [Google Scholar]
  9. Davis R. M., Font R. L., Keisler M. S., Shadduck J. A. Corneal microsporidiosis. A case report including ultrastructural observations. Ophthalmology. 1990 Jul;97(7):953–957. [PubMed] [Google Scholar]
  10. De Groote M. A., Visvesvara G., Wilson M. L., Pieniazek N. J., Slemenda S. B., daSilva A. J., Leitch G. J., Bryan R. T., Reves R. Polymerase chain reaction and culture confirmation of disseminated Encephalitozoon cuniculi in a patient with AIDS: successful therapy with albendazole. J Infect Dis. 1995 May;171(5):1375–1378. doi: 10.1093/infdis/171.5.1375. [DOI] [PubMed] [Google Scholar]
  11. Didier E. S., Didier P. J., Friedberg D. N., Stenson S. M., Orenstein J. M., Yee R. W., Tio F. O., Davis R. M., Vossbrinck C., Millichamp N. Isolation and characterization of a new human microsporidian, Encephalitozoon hellem (n. sp.), from three AIDS patients with keratoconjunctivitis. J Infect Dis. 1991 Mar;163(3):617–621. doi: 10.1093/infdis/163.3.617. [DOI] [PubMed] [Google Scholar]
  12. Didier E. S., Rogers L. B., Brush A. D., Wong S., Traina-Dorge V., Bertucci D. Diagnosis of disseminated microsporidian Encephalitozoon hellem infection by PCR-Southern analysis and successful treatment with albendazole and fumagillin. J Clin Microbiol. 1996 Apr;34(4):947–952. doi: 10.1128/jcm.34.4.947-952.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Didier E. S., Rogers L. B., Orenstein J. M., Baker M. D., Vossbrinck C. R., Van Gool T., Hartskeerl R., Soave R., Beaudet L. M. Characterization of Encephalitozoon (Septata) intestinalis isolates cultured from nasal mucosa and bronchoalveolar lavage fluids of two AIDS patients. J Eukaryot Microbiol. 1996 Jan-Feb;43(1):34–43. doi: 10.1111/j.1550-7408.1996.tb02470.x. [DOI] [PubMed] [Google Scholar]
  14. Diesenhouse M. C., Wilson L. A., Corrent G. F., Visvesvara G. S., Grossniklaus H. E., Bryan R. T. Treatment of microsporidial keratoconjunctivitis with topical fumagillin. Am J Ophthalmol. 1993 Mar 15;115(3):293–298. doi: 10.1016/s0002-9394(14)73578-0. [DOI] [PubMed] [Google Scholar]
  15. Dieterich D. T., Lew E. A., Kotler D. P., Poles M. A., Orenstein J. M. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J Infect Dis. 1994 Jan;169(1):178–183. doi: 10.1093/infdis/169.1.178. [DOI] [PubMed] [Google Scholar]
  16. Dore G. J., Marriott D. J., Hing M. C., Harkness J. L., Field A. S. Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole. Clin Infect Dis. 1995 Jul;21(1):70–76. doi: 10.1093/clinids/21.1.70. [DOI] [PubMed] [Google Scholar]
  17. Edlind T. D., Bartlett M. S., Smith J. W. Characterization of the beta-tubulin gene of Pneumocystis carinii. J Protozool. 1991 Nov-Dec;38(6):62S–63S. [PubMed] [Google Scholar]
  18. Edlind T. D., Li J., Visvesvara G. S., Vodkin M. H., McLaughlin G. L., Katiyar S. K. Phylogenetic analysis of beta-tubulin sequences from amitochondrial protozoa. Mol Phylogenet Evol. 1996 Apr;5(2):359–367. doi: 10.1006/mpev.1996.0031. [DOI] [PubMed] [Google Scholar]
  19. Edlind T., Katiyar S., Visvesvara G., Li J. Evolutionary origins of Microsporidia and basis for benzimidazole sensitivity: an update. J Eukaryot Microbiol. 1996 Sep-Oct;43(5):109S–109S. doi: 10.1111/j.1550-7408.1996.tb05029.x. [DOI] [PubMed] [Google Scholar]
  20. Franssen F. F., Lumeij J. T., van Knapen F. Susceptibility of Encephalitozoon cuniculi to several drugs in vitro. Antimicrob Agents Chemother. 1995 Jun;39(6):1265–1268. doi: 10.1128/aac.39.6.1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Franzen C., Fätkenheuer G., Salzberger B., Müller A., Mahrle G., Diehl V., Schrappe M. Intestinal microsporidiosis in patients with acquired immunodeficiency syndrome--report of three more German cases. Infection. 1994 Nov-Dec;22(6):417–419. doi: 10.1007/BF01715501. [DOI] [PubMed] [Google Scholar]
  22. Franzen C., Müller A., Salzberger B., Fätkenheuer G., Diehl V., Schrappe M. Chronic rhinosinusitis in patients with AIDS: potential role of microsporidia. AIDS. 1996 Jun;10(6):687–688. doi: 10.1097/00002030-199606000-00022. [DOI] [PubMed] [Google Scholar]
  23. Garvey M. J., Ambrose P. G., Ulmer J. L. Topical fumagillin in the treatment of microsporidial keratoconjunctivitis in AIDS. Ann Pharmacother. 1995 Sep;29(9):872–874. doi: 10.1177/106002809502900909. [DOI] [PubMed] [Google Scholar]
  24. Hartwig A., Przelecka A. Nucleic acids in intestine of Apis mellifica infected with Nosema apis and treated with fumagillin DCH: cytochemical and autoradiographic studies. J Invertebr Pathol. 1971 Nov;18(3):331–336. doi: 10.1016/0022-2011(71)90034-6. [DOI] [PubMed] [Google Scholar]
  25. Hori A., Ikeyama S., Sudo K. Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells. Biochem Biophys Res Commun. 1994 Nov 15;204(3):1067–1073. doi: 10.1006/bbrc.1994.2571. [DOI] [PubMed] [Google Scholar]
  26. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., Folkman J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature. 1990 Dec 6;348(6301):555–557. doi: 10.1038/348555a0. [DOI] [PubMed] [Google Scholar]
  27. Jaronski S. T. Cytochemical evidence for RNA synthesis inhibition by fumagillin. J Antibiot (Tokyo) 1972 Jun;25(6):327–331. doi: 10.7164/antibiotics.25.327. [DOI] [PubMed] [Google Scholar]
  28. Joste N. E., Rich J. D., Busam K. J., Schwartz D. A. Autopsy verification of Encephalitozoon intestinalis (microsporidiosis) eradication following albendazole therapy. Arch Pathol Lab Med. 1996 Feb;120(2):199–203. [PubMed] [Google Scholar]
  29. KATZNELSON H., JAMIESON C. A. Control of nosema disease of honeybees with fumagillin. Science. 1952 Jan 18;115(2977):70–71. doi: 10.1126/science.115.2977.70. [DOI] [PubMed] [Google Scholar]
  30. KILLOUGH J. H., MAGILL G. B., SMITH R. C. The treatment of amebiasis with fumagillin. Science. 1952 Jan 18;115(2977):71–72. doi: 10.1126/science.115.2977.71. [DOI] [PubMed] [Google Scholar]
  31. Katiyar S. K., Gordon V. R., McLaughlin G. L., Edlind T. D. Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence. Antimicrob Agents Chemother. 1994 Sep;38(9):2086–2090. doi: 10.1128/aac.38.9.2086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kusaka M., Sudo K., Fujita T., Marui S., Itoh F., Ingber D., Folkman J. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun. 1991 Feb 14;174(3):1070–1076. doi: 10.1016/0006-291x(91)91529-l. [DOI] [PubMed] [Google Scholar]
  33. Lacey E. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int J Parasitol. 1988 Nov;18(7):885–936. doi: 10.1016/0020-7519(88)90175-0. [DOI] [PubMed] [Google Scholar]
  34. Lowder C. Y., McMahon J. T., Meisler D. M., Dodds E. M., Calabrese L. H., Didier E. S., Cali A. Microsporidial keratoconjunctivitis caused by Septata intestinalis in a patient with acquired immunodeficiency syndrome. Am J Ophthalmol. 1996 Jun;121(6):715–717. doi: 10.1016/s0002-9394(14)70642-7. [DOI] [PubMed] [Google Scholar]
  35. McCOWEN M. C., CALLENDER M. E., LAWLIS J. F., Jr Fumagillin (H-3), a new antibiotic with amebicidal properties. Science. 1951 Feb 23;113(2930):202–203. doi: 10.1126/science.113.2930.202. [DOI] [PubMed] [Google Scholar]
  36. Mosmann T. R., Fong T. A. Specific assays for cytokine production by T cells. J Immunol Methods. 1989 Jan 17;116(2):151–158. doi: 10.1016/0022-1759(89)90198-1. [DOI] [PubMed] [Google Scholar]
  37. Orenstein J. M. Microsporidiosis in the acquired immunodeficiency syndrome. J Parasitol. 1991 Dec;77(6):843–864. [PubMed] [Google Scholar]
  38. Rosberger D. F., Serdarevic O. N., Erlandson R. A., Bryan R. T., Schwartz D. A., Visvesvara G. S., Keenan P. C. Successful treatment of microsporidial keratoconjunctivitis with topical fumagillin in a patient with AIDS. Cornea. 1993 May;12(3):261–265. doi: 10.1097/00003226-199305000-00013. [DOI] [PubMed] [Google Scholar]
  39. Schmidt E. C., Shadduck J. A. Mechanisms of resistance to the intracellular protozoan Encephalitozoon cuniculi in mice. J Immunol. 1984 Nov;133(5):2712–2719. [PubMed] [Google Scholar]
  40. Shadduck J. A. Effect of fumagillin on in vitro multiplication of Encephalitozoon cuniculi. J Protozool. 1980 May;27(2):202–208. doi: 10.1111/j.1550-7408.1980.tb04681.x. [DOI] [PubMed] [Google Scholar]
  41. Shadduck J. A., Meccoli R. A., Davis R., Font R. L. Isolation of a microsporidian from a human patient. J Infect Dis. 1990 Sep;162(3):773–776. doi: 10.1093/infdis/162.3.773. [DOI] [PubMed] [Google Scholar]
  42. Shah G. K., Pfister D., Probst L. E., Ferrieri P., Holland E. Diagnosis of microsporidial keratitis by confocal microscopy and the chromatrope stain. Am J Ophthalmol. 1996 Jan;121(1):89–91. doi: 10.1016/s0002-9394(14)70538-0. [DOI] [PubMed] [Google Scholar]
  43. Silveira H., Canning E. U. Vittaforma corneae n. comb. for the human microsporidium Nosema corneum Shadduck, Meccoli, Davis & Font, 1990, based on its ultrastructure in the liver of experimentally infected athymic mice. J Eukaryot Microbiol. 1995 Mar-Apr;42(2):158–165. doi: 10.1111/j.1550-7408.1995.tb01557.x. [DOI] [PubMed] [Google Scholar]
  44. Sobottka I., Albrecht H., Schäfer H., Schottelius J., Visvesvara G. S., Laufs R., Schwartz D. A. Disseminated Encephalitozoon (Septata) intestinalis infection in a patient with AIDS: novel diagnostic approaches and autopsy-confirmed parasitological cure following treatment with albendazole. J Clin Microbiol. 1995 Nov;33(11):2948–2952. doi: 10.1128/jcm.33.11.2948-2952.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sun T., Kaplan M. H., Teichberg S., Weissman G., Smilari T., Urmacher C. Intestinal microsporidiosis. Report of five cases. Ann Clin Lab Sci. 1994 Nov-Dec;24(6):521–532. [PubMed] [Google Scholar]
  46. Teicher B. A., Holden S. A., Ara G., Dupuis N. P., Liu F., Yuan J., Ikebe M., Kakeji Y. Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy. Int J Cancer. 1995 May 29;61(5):732–737. doi: 10.1002/ijc.2910610523. [DOI] [PubMed] [Google Scholar]
  47. Tsujimoto H., Hagiwara A., Osaki K., Ohyama T., Sakakibara T., Sakuyama A., Ohgaki M., Imanishi T., Watanabe N., Yamazaki J. Therapeutic effects of the angiogenesis inhibitor TNP-470 against carcinomatous peritonitis in mice. Anticancer Drugs. 1995 Jun;6(3):438–442. doi: 10.1097/00001813-199506000-00012. [DOI] [PubMed] [Google Scholar]
  48. Weber R., Bryan R. T., Schwartz D. A., Owen R. L. Human microsporidial infections. Clin Microbiol Rev. 1994 Oct;7(4):426–461. doi: 10.1128/cmr.7.4.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Weber R., Sauer B., Spycher M. A., Deplazes P., Keller R., Ammann R., Briner J., Lüthy R. Detection of Septata intestinalis in stool specimens and coprodiagnostic monitoring of successful treatment with albendazole. Clin Infect Dis. 1994 Aug;19(2):342–345. doi: 10.1093/clinids/19.2.342. [DOI] [PubMed] [Google Scholar]
  50. Wilkins J. H., Joshi N., Margolis T. P., Cevallos V., Dawson C. R. Microsporidial keratoconjunctivitis treated successfully with a short course of fumagillin. Eye (Lond) 1994;8(Pt 6):703–704. doi: 10.1038/eye.1994.177. [DOI] [PubMed] [Google Scholar]
  51. Yamaoka M., Yamamoto T., Ikeyama S., Sudo K., Fujita T. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res. 1993 Nov 1;53(21):5233–5236. [PubMed] [Google Scholar]
  52. Yamaoka M., Yamamoto T., Masaki T., Ikeyama S., Sudo K., Fujita T. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res. 1993 Sep 15;53(18):4262–4267. [PubMed] [Google Scholar]
  53. Yanai S., Okada H., Saito K., Kuge Y., Misaki M., Ogawa Y., Toguchi H. Antitumor effect of arterial administration of a medium-chain triglyceride solution of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX-2 carcinoma. Pharm Res. 1995 May;12(5):653–657. doi: 10.1023/a:1016243105622. [DOI] [PubMed] [Google Scholar]
  54. Yanase T., Tamura M., Fujita K., Kodama S., Tanaka K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res. 1993 Jun 1;53(11):2566–2570. [PubMed] [Google Scholar]
  55. van Gool T., Snijders F., Reiss P., Eeftinck Schattenkerk J. K., van den Bergh Weerman M. A., Bartelsman J. F., Bruins J. J., Canning E. U., Dankert J. Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique. J Clin Pathol. 1993 Aug;46(8):694–699. doi: 10.1136/jcp.46.8.694. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES